...We Welcome You To The Resverlogix HUB withIn The AGORACOM COMMUNITY!

Free
Message: No news

tada, here is the recap of Zenith's ZEN-3694-Combination, Clinical Trials:

https://www.cancer.gov/about-cancer/treatment/clinical-trials/intervention/bet-bromodomain-inhibitor-zen-3694

 

Koo

Share
New Message
Please login to post a reply